Results 171 to 180 of about 7,868 (215)

Nonmetastatic Gestational Trophoblastic Disease

Obstetrics and Gynecology Clinics of North America, 1988
Nonmetastatic gestational trophoblastic disease encompasses a variety of related neoplasms of the human placenta. With the advent of effective chemotherapy, nearly all of these patients can be cured using a variety of regimens with acceptable toxicity.
J T, Soper, C B, Hammond
openaire   +2 more sources

Treatment of gestational trophoblastic disease

American Journal of Obstetrics and Gynecology, 1974
Abstract Of 39 patients undergoing chemotherapy for gestational trophoblastic disease, 92 per cent are in remission. More than half of the patients treated (54 per cent) had metastatic disease on admission to the hospital, and 85 per cent of these are in remission. An inordinately large number of patients were in the high-risk category (71.4 per cent)
W B, Jones, J L, Lewis
openaire   +2 more sources

Recurrent gestational trophoblastic disease

Gynecologic Oncology, 1981
Abstract A retrospective analysis of all patients treated at Duke University Medical Center for recurrent malignant gestational trophoblastic disease is presented. Four patients (3%) with nonmetastatic disease developed recurrent tumor in the uterus from 1 month to 3 years after achieving primary remission. Eleven patients (26%) in the poor prognostic
E A, Surwit, C B, Hammond
openaire   +2 more sources

Imaging in Gestational Trophoblastic Disease

Seminars in Ultrasound, CT and MRI, 2019
Gestational trophoblastic disease (GTD) is a spectrum of disorders characterized by abnormal trophoblastic proliferation. GTD includes benign conditions such as hydatidiform moles and malignant diseases that are referred as gestational trophoblastic neoplasia (GTN).
Lawrence Hsu, Lin, Rodrigo, Polizio, Koji, Fushida, Rossana Pulcineli Vieira, Francisco   +3 more
openaire   +2 more sources

Immunobiology of gestational trophoblastic diseases

International Journal of Gynecological Cancer, 2006
Gestational trophoblastic diseases (GTDs) comprise a group of interrelated diseases characterized by development after gestation, widespread metastases, and high curability with chemotherapy. The good prognosis of GTDs is considered partly a result of the host immune response to paternal antigens expressed on trophoblastic cells.
X, Wang, S, Fu, R S, Freedman, J, Liu, J J, Kavanagh   +4 more
openaire   +2 more sources

Treating gestational trophoblastic disease

Expert Opinion on Pharmacotherapy, 2010
Gestational trophoblastic disease is one of the few human malignancies that is curable, even in advanced stages of the disease. However, appropriate management and follow-up are essential components in curing this disease.Observational, retrospective and prospective studies evaluating the efficacy of medical and surgical management of gestational ...
Noah, Rodriguez, Donald P, Goldstein, Ross S, Berkowitz   +2 more
openaire   +2 more sources

Epidemiology of gestational trophoblastic diseases

Best Practice & Research Clinical Obstetrics & Gynaecology, 2003
The epidemiology of gestational trophoblastic diseases is unclear. Problems with collection and interpretation of differing data abound. Hydatidiform mole (HM) is associated with abnormal gametogenesis and/or fertilization. This is further influenced by age, ethnicity and a prior history of an HM suggesting a genetic basis for its aetiology.
openaire   +2 more sources

Recognising gestational trophoblastic disease

Best Practice & Research Clinical Obstetrics & Gynaecology, 2009
Gestational trophoblastic disease (GTD) is a group of interrelated tumours originating from the placenta. Hydatidiform molar (HM) pregnancy is the most common form of GTD; this includes both partial hydatidiform molar (PHM) and complete hydatidiform molar (CHM) pregnancies.
Dalya, Alhamdan, Tommaso, Bignardi, George, Condous   +2 more
openaire   +2 more sources

Pathology of gestational trophoblastic disease (GTD)

Best Practice & Research Clinical Obstetrics & Gynaecology, 2021
Gestational trophoblastic disease (GTD), comprising hydatidiform moles (HM) and gestational trophoblastic tumors (GTT), is extremely rare. HM originate from villous trophoblast and are considered preneoplastic. GTT originate from the intermediate, largely extravillous trophoblast and includes choriocarcinoma, placental site trophoblastic tumor ...
openaire   +3 more sources

Gestational trophoblastic diseases.

Journal of epidemiology and biostatistics, 2001
link_to_subscribed_fulltext
Ngan, H. Y, ODICINO, Franco, Maisonneuve, P, Beller, U, Benedet, J. L, Heintz, A. P, PECORELLI, Sergio, Sideri, M, Creasman, W. T.   +8 more
openaire   +3 more sources